Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

NeuroPace (NPCE) Accumulated Expenses (2020 - 2026)

NeuroPace has reported Accumulated Expenses over the past 7 years, most recently at $9.3 million for Q1 2026.

  • For Q1 2026, Accumulated Expenses rose 15.96% year-over-year to $9.3 million; the TTM value through Mar 2026 reached $9.3 million, up 15.96%, while the annual FY2025 figure was $13.3 million, 36.29% up from the prior year.
  • Accumulated Expenses for Q1 2026 was $9.3 million at NeuroPace, down from $13.3 million in the prior quarter.
  • Over five years, Accumulated Expenses peaked at $13.3 million in Q4 2025 and troughed at $6.6 million in Q1 2023.
  • A 5-year average of $9.0 million and a median of $8.2 million in 2023 define the central range for Accumulated Expenses.
  • Biggest five-year swings in Accumulated Expenses: surged 87.73% in 2022 and later decreased 12.46% in 2024.
  • Year by year, Accumulated Expenses stood at $7.4 million in 2022, then skyrocketed by 50.8% to $11.2 million in 2023, then fell by 12.46% to $9.8 million in 2024, then surged by 36.29% to $13.3 million in 2025, then dropped by 29.95% to $9.3 million in 2026.
  • Business Quant data shows Accumulated Expenses for NPCE at $9.3 million in Q1 2026, $13.3 million in Q4 2025, and $12.3 million in Q3 2025.